Beyond sequencing: prioritizing and delivering neoantigens for cancer vaccines

AS Roesler, KS Anderson - … Design: Methods and Protocols, Volume 1 …, 2021 - Springer
Neoantigens are tumor-specific proteins and peptides that can be highly immunogenic.
Immune-mediated tumor rejection is strongly associated with cytotoxic responses to …
被引用次数：11 相关文章

Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines

AS Roesler, KS Anderson - Methods in Molecular Biology, 2022 - asu.elsevierpure.com
Neoantigens are tumor-specific proteins and peptides that can be highly immunogenic.
Immune-mediated tumor rejection is strongly associated with cytotoxic responses to …

Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines.

AS Roesler, KS Anderson - Methods in Molecular Biology (Clifton …, 2022 - europepmc.org
Neoantigens are tumor-specific proteins and peptides that can be highly immunogenic.
Immune-mediated tumor rejection is strongly associated with cytotoxic responses to …

Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines

AS Roesler, KS Anderson - Vaccine Design - Springer
Neoantigens are tumor-specific proteins and peptides that can be highly immunogenic.
Immune-mediated tumor rejection is strongly associated with cytotoxic responses to …

Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines

AS Roesler, KS Anderson - Methods in molecular biology …, 2022 - pubmed.ncbi.nlm.nih.gov
Neoantigens are tumor-specific proteins and peptides that can be highly immunogenic.
Immune-mediated tumor rejection is strongly associated with cytotoxic responses to …